Dr Bradley Wong
MBBS, FRANZCR
For patients/carers
For doctors
MBBS, FRANZCR
Locations
Gympie Specialist Clinic
71 Channon Street, Gympie 457
Availability: Fortnightly on Thursdays
Clinical interests
- Prostate cancer
- Skin cancer
- Benign conditions
- Genitourinary cancer
- Breast cancer
Languages
Fluent
- English
Biography
Clinical interests include skin, prostate and urological cancers, benign conditions (osteoarthritis, Dupuytren's & Ledderhose disease, plantar fasciitis and keloid scars) and palliative radiation therapy.
Brad completed a Bachelor of Medicine and Surgery (MBBS) at the University of Adelaide before undertaking his radiation oncology training in South Australia. In 2015, he was awarded Fellowship of the Royal Australian and New Zealand College of Radiologists (FRANZCR). He practices as a consultant radiation oncology specialist with GenesisCare in Buderim and Noosa with an outreach clinic in Gympie.
Brad is dedicated to offering personalised care through the provision of modern treatment techniques, including volumetric modulated arc therapy (VMAT), image-guided radiation therapy (IGRT), stereotactic ablative radiotherapy (SABR) and the use of rectal spacing to reduce side effects in prostate cancer patients. In recent years, Brad has presented at a number of medical conferences on the topics of skin cancer and prostate cancer. He regularly participates in multidisciplinary team meetings and believes in a holistic approach to patient care.
Brad works collaboratively with the GenesisCare prostate cancer support nurse to achieve the best possible outcomes for prostate cancer patients. He is an active participant in clinical research and is currently recruiting to the ASTuTE study for patients with intermediate-risk prostate cancer and the PROSPECT-OA registry for patients with osteoarthritis.
Brad is an active member of the Sunshine Coast medical community and sits on the management committee for the Sunshine Coast Local Medical Association (SCLMA). He serves on the GenesisCare national Expert Advisory Group (EAG) for benign diseases and chairs the national benign and complex skin MDT. He has previously served as the chairman of the Wide Bay Urology MDT. Brad has involvement in clinical teaching and has previously been awarded the academic title of Senior Lecturer at the University of Queensland School of Medicine.
Brad works across many tumour types and has clinical interests in the management of skin cancer, prostate and urological cancer, benign conditions (osteoarthritis, Dupuytren's & Ledderhose disease, plantar fasciitis, keloid scars) and palliative radiation therapy. His current major technical interests are in the use of custom bolus for wide-field skin treatments.
More information
- Senior Lecturer, School of Medicine, University of Queensland
- Clinical Examiner, School of Medicine, University of Queensland, Rural Clinical School, Bundaberg
- Fellowship of the Royal Australian and New Zealand College of Radiologists (FRANZCR)
- PROSPECT-OA registry for patients with osteoarthritis
- ASTuTE study for patients with intermediate-risk prostate cancer
- Skin cancer treatments using modern technology including the creation of custom bolus
- Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP)
- Urological Society of Australia and New Zealand (USANZ)
- Australasian Society for Breast Disease (ASBD)
- International Dupuytren Society
- International Organisation for Radiotherapy for Benign Conditions (IORBC)
- Royal Australian and New Zealand College of Radiologists (RANZCR)
- Trans-Tasman Radiation Oncology Group (TROG)
- Breast Cancer Trials Group (BCT)
- Artificial Intelligence impact on decision-making regarding short-term ADT with prostate radiotherapy: ASTuTE clinical trial interim results, Clinical and Translational Radiation Oncology, 2026
- A multicentre implementation trial of an Artificial Intelligence-driven biomarker to inform Shared decisions for androgen deprivation therapy in men undergoing prostate radiotherapy: the ASTuTE protocol, BMC Cancer, 2025
- Keratinocyte cancer of the lower limb in the frail elderly – acceptable results for 96 lesions treated with a shortened radiotherapy protocol: International Journal of Radiology & Radiation Therapy, 2024
- Modern radiation therapy for keratinocyte cancer: What the general practitioner needs to know, The Australian Journal of General Practice, 2024
- Efficacy and safety analysis: 24‐month outcomes from a prospective cohort of 106 fields treated with widefield radiation therapy for extensive skin field cancerization, with or without keratinocyte cancers, Journal of the European Academy of Dermatology & Venereology, 2023
- Novel radiation approach using volumetric modulated arc therapy for patients with extensive skin field cancerisation and keratinocyte cancers: promising efficacy and safety results for 83 patients, Journal of Dermatological Treatment, 2022
- Role of radiation therapy in the management of patients with widespread non-melanoma skin cancer in regional communities, Dermatology Republic, 2022
- Volumetric modulated arc therapy (VMAT) for extensive skin field cancerisation (ESFC) – exploring the limits of treatment volumes with a case series of backs, International Journal of Radiology & Radiation Therapy, 2020
- Experiences in growing a skin radiation therapy practice, International Journal of Radiology & Radiation Therapy, 2020
- A technique for treating extended skin field cancerisation using volumetric modulated arc therapy, International Journal of Radiology & Radiation Therapy, 2019
- Glomus Jugulare Tumours: A fifteen year radiotherapy experience in South Australia, Journal of Clinical Neuroscience, 2014
Brad loves spending time with his young daughter, wife and French bulldogs. He previously completed the Gold Coast Marathon but claims it's "one and done"!
